News Sentiment

INSP sentiment intelligence

Inspire Medical Systems Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 49 Balanced news tone 65 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 51.76 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 65

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+10.2% over one week, +21.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction 10.2% Price confirming higher
Trend fit Trend inactive 21.2% over four weeks
Fair value -64.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 50
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 65
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
Stock Titan 5
StockStory 4
simplywall.st 4
TradingView 3
GlobeNewswire 2
www.marketscreener.com 2
marketscreener.com 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 20
Analyst action 9
Regulatory and legal 5
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 65
Pluang Direct company coverage

Investigation continues into Inspire Medical Systems over delayed product launch and earnings cut.

Kahn Swick & Foti, LLC is investigating Inspire Medical Systems due to delays in launching its Inspire V device and a significant cut in its 2025 earnings guidance. The delays stem from issues like incomplete training, software problems, and excess inventory. Inspire and some exe

Tone
Neutral 50/100
Event
Regulatory and legal
Published
11 Jul 2026 18:42
Source
Pluang
PR Newswire Direct company coverage

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Inspire Medical Systems, Inc. (NYSE: INSP) and its officers and directors. This follows a previous securities class action lawsuit filed after the company disclosed significant issues with the launch of its Inspire

Tone
Negative 29/100
Event
Regulatory and legal
Published
11 Jul 2026 02:10
Source
PR Newswire
MarketBeat Direct company coverage

Inspire Medical Systems (INSP) Short Interest & Short Float | Updated Jul 2026 $INSP

Inspire Medical Systems (INSP) experienced a 30.79% increase in short interest, reaching 4.69 million shares sold short as of June 30, 2026. This represents 16.66% of the public float, with a short interest ratio of 3.8 days to cover. The change indicates a growing bearish sentim

Tone
Negative 40/100
Event
Market update
Published
10 Jul 2026 18:42
Source
MarketBeat
TradingView Direct company coverage

Price to sales forward of Inspire Medical Systems, Inc. – NYSE:INSP

This article displays the "Price to sales forward" metric for Inspire Medical Systems, Inc. (NYSE: INSP) on TradingView. It presents financial data for the company, indicating key statistical values over a specific period, and notes that the information was made by humans.

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 17:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Inspire Medical Systems, Inc. – NYSE:INSP

The article displays the enterprise value to EBIT forward for Inspire Medical Systems, Inc. (NYSE: INSP) within the TradingView platform. It presents financial overview information for the company, accessible through various features of the platform like charts, screeners, and ne

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 14:09
Source
TradingView
TradingView Direct company coverage

ETFs Investing in Inspire Medical Systems, Inc. Stocks

This article lists various ETFs that hold stock in Inspire Medical Systems, Inc. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, change, and 3-year NAV total return. The ETFs predominantly focus o

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 22:11
Source
TradingView
StockStory Direct company coverage

2 Reasons INSP is Risky and 1 Stock to Buy Instead

Inspire Medical Systems (INSP) shares have dropped significantly, prompting analysis of its future prospects. The article identifies two key risks: limited distribution channels due to its smaller size, hindering economies of scale and trust-building in a regulated industry, and

Tone
Negative 29/100
Event
Market update
Published
09 Jul 2026 07:11
Source
StockStory
The National Law Review Direct company coverage

Investors in Inspire Medical Systems, Inc. (INSP): Protect Your Rights - Contact Levi & Korsinsky Before January 5, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Inspire Medical Systems, Inc. (INSP) on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and co

Tone
Negative 19/100
Event
Regulatory and legal
Published
08 Jul 2026 05:10
Source
The National Law Review
Simply Wall Street Direct company coverage

Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls

Inspire Medical Systems (INSP) is under scrutiny following Class II device recalls for incorrect labeling, impacting selected units in the US and Hong Kong. Despite this, the stock has recently rebounded by 20.05% after significant year-to-date and one-year declines. A popular na

Tone
Neutral 50/100
Event
Regulatory and legal
Published
07 Jul 2026 17:40
Source
Simply Wall Street
GlobeNewswire Direct company coverage

Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

Inspire Medical Systems, Inc. (NYSE: INSP) announced a correction to its previous press release, confirming that its second quarter 2026 financial results will be released after the close of trading on Monday, August 3, 2026. The company's management team will host a conference c

Tone
Neutral 50/100
Event
Earnings
Published
07 Jul 2026 05:10
Source
GlobeNewswire
scanx.trade Direct company coverage

Inspire Medical Systems to report Q2 2026 results on August 3

Inspire Medical Systems, Inc. announced it will release its second-quarter 2026 financial results after market close on Monday, August 3, 2026. A conference call will be held at 5:00 p.m. Eastern Time for the management team to discuss the results and recent business developments

Tone
Negative 36/100
Event
Earnings
Published
06 Jul 2026 19:41
Source
scanx.trade
GlobeNewswire Direct company coverage

Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026

Inspire Medical Systems, Inc. announced it will release its second quarter 2026 financial results after the close of trading on Monday, August 3, followed by a conference call at 5:00 p.m. ET to discuss the results and business developments. The company initially provided an inco

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 17:09
Source
GlobeNewswire
Stock Titan Direct company coverage

Inspire Medical corrects Q2 2026 results date to Aug. 3

Inspire Medical Systems (NYSE: INSP) has corrected the date for its second-quarter 2026 financial results release to Monday, August 3, 2026, after market close. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and business d

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 14:13
Source
Stock Titan
Stock Titan Direct company coverage

Inspire Medical sets Aug. 3 earnings call after Q2 results

Inspire Medical Systems (NYSE: INSP) will release its second quarter 2026 financial results after the market close on Monday, August 3, 2026. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and recent business developments.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 12:13
Source
Stock Titan
The Globe and Mail Direct company coverage

Inspire Medical Systems (INSP) Gets a Hold from Wells Fargo

Wells Fargo analyst Larry Biegelsen maintained a Hold rating for Inspire Medical Systems (INSP) with a price target of $56.00, while the company's shares closed at $46.95. This follows a similar Hold rating from Evercore ISI, though Freedom Capital Markets initiated coverage with

Tone
Neutral 50/100
Event
Analyst action
Published
04 Jul 2026 16:40
Source
The Globe and Mail
Stock Titan Direct company coverage

Inspire Medical Systems (NASDAQ: INSP) D.E. Shaw affiliate reports 5.1% holding

D. E. Shaw & Co., L.P. and its affiliates have reported a 5.1% beneficial ownership stake in Inspire Medical Systems (NASDAQ: INSP), totaling 1,483,107 shares of common stock. The Schedule 13G filing indicates shared voting power over 1,374,263 shares and shared dispositive power

Tone
Neutral 50/100
Event
Deals and strategy
Published
02 Jul 2026 19:40
Source
Stock Titan
Finviz Direct company coverage

INSP - Inspire Medical Systems Inc Options

This article provides a detailed financial overview of Inspire Medical Systems Inc (INSP), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance indicators, analyst recommendations, and insider/institut

Tone
Neutral 50/100
Event
Analyst action
Published
02 Jul 2026 17:09
Source
Finviz
GuruFocus Direct company coverage

INSP Initiates Coverage On Inspire Medical Systems -- Rating Buy

Freedom Capital Markets initiated coverage on Inspire Medical Systems (INSP) with a "Buy" rating and a price target of $62.00, suggesting a significant upside from its current trading price of $44.61. The company is considered undervalued according to GuruFocus's GF Value™ and sh

Tone
Positive 82/100
Event
Analyst action
Published
01 Jul 2026 12:14
Source
GuruFocus
Investing.com Direct company coverage

Inspire Medical shares initiated at buy by Freedom Capital on valuation

Freedom Capital has initiated coverage on Inspire Medical Systems Inc. (NYSE:INSP) with a "buy" rating and a price target of $62.00, suggesting a 39% upside from its current price. Despite potential near-term volatility from reimbursement issues and competition, the firm believes

Tone
Positive 61/100
Event
Analyst action
Published
01 Jul 2026 01:40
Source
Investing.com
www.marketscreener.com Direct company coverage

Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Index

Inspire Medical Systems, Inc. (NYSE: INSP) has been added to the Russell 2000 Index, as well as the Russell 2000 Value and Russell 2000 Growth Benchmarks. Simultaneously, the company was dropped from several other Russell indices, including the Russell Midcap Growth, Russell 1000

Tone
Positive 65/100
Event
Market update
Published
29 Jun 2026 18:39
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Inspire Medical Systems, Inc.(NYSE:INSP) dropped from Russell Midcap Growth Benchmark

Inspire Medical Systems, Inc. (NYSE:INSP) has been dropped from the Russell Midcap Growth Benchmark. This news comes alongside several other index changes for the company, including being added to the Russell 2000 Index, Russell 2000 Value Benchmark, and Russell 2000 Growth Bench

Tone
Negative 37/100
Event
Market update
Published
29 Jun 2026 17:12
Source
www.marketscreener.com
Sahm Direct company coverage

Why Inspire Medical Systems (INSP) Is Up 10.6% After Russell Index Reclassification To Small Cap

Inspire Medical Systems (INSP) saw its stock rise by 10.6% after being reclassified from the Russell 1000 to smaller-cap Russell indices like the Russell 2000. This shift may alter its investor base and position sizing, though the underlying investment narrative for its obstructi

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 15:40
Source
Sahm